Mark Versavel

Mark Versavel is a seasoned clinical pharma consultant and the President of vZenium LLC, a life science consulting firm focused on neurological and psychiatric diseases. Currently serving as the Medical Director at Cognitive Research Corporation and a Fractional CMO at Consano Bio, Mark has previously held numerous leadership positions, including Chief Medical Officer at NeuroBo Pharmaceuticals and Alzheon, Inc. Mark's extensive experience in clinical development encompasses roles at Pfizer and Sunovion Pharmaceuticals, leading critical research efforts in CNS disorders. Mark holds an MD from Universiteit Antwerpen, a Dr. Med from Humboldt-Universität zu Berlin, and an MBA from the University of Michigan.